ASPirin Intervention for the REDuction of Colorectal Cancer Risk

Research Group
Gastrointestinal and Other Cancers
Sponsor
Massachusetts General Hospital
Status
Active, not recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT02394769
This research study is investigating the use of aspirin as a potential chemopreventive agent to reduce risk of colorectal cancer
Intervention
Placebo for Aspirin, Aspirin
Condition
Colorectal Cancer
Investigators
Andrew T Chan, MD, MPH

See list of participating sites